PNC Financial Services Group’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $24.4K | Hold |
|
|||||
|
2024
Q4 | $25.8K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $108K | Hold |
|
|||||
|
2023
Q2 | $80.9K | Hold |
|
|||||
|
2023
Q1 | $118K | Hold |
|
|||||
|
2022
Q4 | $63.5K | Hold |
|
|||||
|
2022
Q3 | $92K | Hold |
|
|||||
|
2022
Q2 | $74K | Hold |
|
|||||
|
2022
Q1 | $90K | Buy |
|
|||||
|
2021
Q4 | $96K | Hold |
|
|||||
|
2021
Q3 | $179K | Sell |
|
|||||
|
2021
Q2 | $149K | Buy |
|
|||||
|
2021
Q1 | $100K | Hold |
|
|||||
|
2020
Q4 | $103K | Sell |
|
|||||
|
2020
Q3 | $181K | Hold |
|
|||||
|
2020
Q2 | $208K | Hold |
|
|||||
|
2020
Q1 | $133K | Hold |
|
|||||
|
2019
Q4 | $194K | Hold |
|
|||||
|
2019
Q3 | $249K | Buy |
|
|||||
|
2019
Q2 | $270K | Buy |
|
|||||
|
2019
Q1 | $241K | Hold |
|
|||||
|
2018
Q4 | $162K | Hold |
|
|||||
|
2018
Q3 | $283K | Sell |
|
|||||
|
2018
Q2 | $332K | Buy |
|
|||||
|
2018
Q1 | $243K | Hold |
|
|||||
|
2017
Q4 | $171K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $0 | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $1K | Hold |
|
|||||
|
2015
Q2 | $1K | Buy |
|
|||||
|
2015
Q1 | $1K | Buy |
|